Biostar Pharmaceuticals, Inc. Receives Government Approvals for Three New Products
The Approvals and Products Launching Scheduled for Late July 2009 Create New Growth Opportunities XIANYANG, China, July 16 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplie...
Biostar Pharmaceuticals, Inc. Commences the Full Implementation of New Rural Cooperative Supply Network Plan
Biostar's products have reached 1300 sales outlets in untapped rural markets Biostar plans to expand the network to cover 10,000 sales outlets by 2011 XIANYANG, China, July 7 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"),...
Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
XIANYANG, China, June 29 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions,...
Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
NEW YORK and XIANYANG, China, June 15 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a leading manufacturer and supplier of pharmaceutical and medical nutrients addressing a variety of diseases and conditions through its wh...
Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
Investments in Infrastructure Expected to Positively Effect Performance This Year NEW YORK, May 27 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. ("Biostar" or the "Company") (OTC Bulletin Board: BSPM) today reported financial results for the three months ended March 31, 2009. Th...
Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
Sales Up 118% to $33 Million, Net Income Increased 69% to $6.7 Million Over Prior Year NEW YORK, April 7 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. ("Biostar" or the "Company") (OTC Bulletin Board: BSPM) today reported financial results for the 12 months ended December 31, 2008. ...
